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Roles of rapsyn and agrin in interaction of postsynaptic proteins
with acetylcholine receptors
Abstract
At the neuromuscular junction, aggregates of acetylcholine receptors (AChRs) are anchored in the
muscle membrane by association with rapsyn and other postsynaptic proteins. We have investigated the
interactions between the AChR and these proteins in cultured C2 myotubes before and after treatment
with agrin, a nerve-derived protein that induces AChRs to cluster. When AChRs were isolated from
detergent extracts of untreated C2 myotubes, they were associated with rapsyn and, to a lesser degree,
with utrophin, beta-dystroglycan, MuSK, and src-related kinases, but not with syntrophin. Treatment
with agrin increased the association of AChRs with MuSK, a receptor tyrosine kinase that forms part of
the agrin receptor complex, without affecting other interactions. Analysis of rapsyn-deficient myotubes,
which do not form protein clusters in response to agrin, revealed that rapsyn is required for association
of the AChR with utrophin and beta-dystroglycan, and for the agrin-induced increase in association with
MuSK, but not for constitutive interactions with MuSK and src-related kinases. In rapsyn -/- myotubes,
agrin caused normal tyrosine phosphorylation of AChR-associated and total MuSK, whereas
phosphorylation of the AChR beta subunit, both constitutive and agrin-induced, was strongly reduced.
These results show first that aneural myotubes contain preassembled AChR protein complexes that may
function in the assembly of the postsynaptic apparatus, and second that rapsyn, in addition to its role in
AChR phosphorylation, mediates selected protein interactions with the AChR and serves as a link
between the AChR and the dystrophin/utrophin glycoprotein complex.
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At the neuromuscular junction, aggregates of acetylcholine
receptors (AChRs) are anchored in the muscle membrane by
association with rapsyn and other postsynaptic proteins. We
have investigated the interactions between the AChR and these
proteins in cultured C2 myotubes before and after treatment
with agrin, a nerve-derived protein that induces AChRs to
cluster. When AChRs were isolated from detergent extracts of
untreated C2 myotubes, they were associated with rapsyn and,
to a lesser degree, with utrophin, b-dystroglycan, MuSK, and
src-related kinases, but not with syntrophin. Treatment with
agrin increased the association of AChRs with MuSK, a recep-
tor tyrosine kinase that forms part of the agrin receptor com-
plex, without affecting other interactions. Analysis of rapsyn-
deficient myotubes, which do not form protein clusters in
response to agrin, revealed that rapsyn is required for associ-
ation of the AChR with utrophin and b-dystroglycan, and for the
agrin-induced increase in association with MuSK, but not for
constitutive interactions with MuSK and src-related kinases. In
rapsyn 2/2 myotubes, agrin caused normal tyrosine phosphor-
ylation of AChR-associated and total MuSK, whereas phos-
phorylation of the AChR b subunit, both constitutive and agrin-
induced, was strongly reduced. These results show first that
aneural myotubes contain preassembled AChR protein com-
plexes that may function in the assembly of the postsynaptic
apparatus, and second that rapsyn, in addition to its role in
AChR phosphorylation, mediates selected protein interactions
with the AChR and serves as a link between the AChR and the
dystrophin/utrophin glycoprotein complex.
Key words: synaptogenesis; acetylcholine receptor; agrin;
rapsyn; neuromuscular junction; tyrosine phosphorylation; pro-
tein interactions
The accumulation of acetylcholine receptors (AChRs) is a char-
acteristic feature of the postsynaptic membrane at the neuromus-
cular junction and is believed to arise through interactions with
the cytoskeleton (Froehner, 1991; Hall and Sanes, 1993). Little
information is available, however, about the interactions of the
AChR with other muscle proteins and how they change during
development (Colledge and Froehner, 1998a).
The specialized postsynaptic membrane is formed through the
action of agrin, a neurally released protein necessary for synapse
formation in vivo (McMahan, 1990; Gautam et al., 1996). When
added to cultured myotubes in vitro or supplied by injected myo-
fibers in vivo, agrin also causes aggregation of AChRs, acetylcho-
linesterase, and other synaptic proteins (Wallace, 1989; Ferns et
al., 1992; Reist et al., 1992; Cohen et al., 1997; Meier et al., 1997).
Little is known about the signaling pathway of agrin, but the
receptor tyrosine kinase MuSK (Jennings et al., 1993; Valenzuela
et al., 1995) appears to be a key component of the agrin receptor
(Glass et al., 1996). MuSK is activated by agrin, and mice lacking
MuSK are similar to agrin-deficient animals in that they lack
AChR clusters (DeChiara et al., 1996). Agrin also induces ty-
rosine phosphorylation of the b subunit of the AChR (Wallace et
al., 1991; Meier et al., 1995; Ferns et al., 1996), a modification
whose significance for AChR clustering is unclear at present
(Meyer and Wallace, 1998). This phosphorylation appears not to
occur through the direct action of MuSK (Fuhrer et al., 1997) but
rather through one or several downstream kinases, possibly of the
src family (Swope and Huganir, 1993, 1994; Fuhrer and Hall,
1996).
One protein closely associated with AChRs is rapsyn, a 43 kDa
peripheral membrane protein (Burden et al., 1983; LaRochelle
and Froehner, 1986). Rapsyn is essential for AChR clustering:
rapsyn-negative mice lack AChR clusters and their cultured myo-
tubes fail to respond to agrin (Gautam et al., 1995), and rapsyn
causes AChR aggregation upon coexpression in heterologous
cells (Froehner et al., 1990; W. P. Phillips et al., 1991). When
coexpressed in QT-6 fibroblasts, rapsyn is also able to aggregate
MuSK and dystroglycan and to activate MuSK (Apel et al., 1995,
1997; Gillespie et al., 1996). On the basis of such indirect evi-
dence, rapsyn has been proposed to link the AChR to the dys-
trophin/utrophin glycoprotein complex (Apel and Merlie, 1995);
rapsyn has also been postulated to link the AChR to MuSK and
to mediate interaction of the AChR with src-family kinases (Apel
et al., 1997).
Although considerable evidence, based largely on expression in
QT-6 fibroblasts, supports either the direct or indirect association
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of the AChR with other synaptic proteins, direct biochemical
evidence for these interactions is lacking. To investigate these
associations and the effect of agrin on them, we have isolated the
AChR from extracts of C2 and rapsyn-negative myotubes and
have used immunological methods to detect proteins that are
specifically associated with it. Our data suggest that aneural
myotubes contain preassembled AChR complexes, that agrin
increases selected protein interactions, and that rapsyn mediates
some but not all associations of other proteins with the AChR.
MATERIALS AND METHODS
Cell culture. Cell culture reagents were purchased from Life Technolo-
gies (Gaithersburg, MD). COS and C2C12 muscle cells were grown at
37°C in 8% CO2. COS cells were maintained in DMEM with 4.5 gm/l
D-glucose containing 10% fetal bovine serum, 2 mM glutamine, and
penicillin /streptomycin. C2C12 mouse muscle cells were grown as myo-
blasts on 10 or 15 cm tissue culture dishes (Nunc, Naperville, IL) in
DMEM supplemented with 20% fetal bovine serum, 0.5% chick embryo
extract, 2 mM glutamine, and penicillin /streptomycin. Cells were shifted
to fusion medium containing DMEM, 5% horse serum, and 2 mM
glutamine after reaching 90% confluence. Formation of myotubes was
generally evident after 1 d in fusion medium. Cultures were harvested for
experiments on day 2 in fusion medium, by which time contracting
myotubes were detectable. Rapsyn 2/2 (clones 11-4 and 11-7) and
rapsyn wild-type (clone 12-10) myoblasts were grown in the same basic
medium as C2 cells, with an additional 4 U/ml g-interferon (g-IFN).
These cells were grown on dishes coated with 0.2% gelatin (Sigma, St.
Louis, MO) and maintained at 33°C with 5% CO2. To induce fusion,
confluent cultures were shifted to C2 fusion medium and 37°C, 5% CO2 ;
the medium was replaced every 2 d. Myotubes started to form after ;1.5
d and were used for experiments after 3 or 4 d in fusion medium.
Expression of agrin constructs. The C-terminal half of agrin isoforms
was expressed in transfected COS cells to obtain soluble forms of agrin.
Constructs encoding the most active, neural-specific isoform (C-Ag12,4,8 )
or the predominant muscle isoform (C-Ag12,0,0 ) (Ferns et al., 1993) were
expressed in COS cells using an adenovirus-mediated DEAE-dextran
method of transfection (Forsayeth and Garcia, 1994). Because these two
splice isoforms of agrin are most prominent and widely used, we refer to
neural agrin as “4,8” and muscle agrin as “0,0” (e.g., see Figs. 2, 6). After
transfection of agrin constructs, the medium was collected and replaced
each day for 3 d. The concentration of agrin in the medium was deter-
mined by immunoblotting using an agrin-specific antiserum and purified
agrin of known concentration as a standard, as described previously
(Fuhrer et al., 1997).
Generation of rapsyn 2/2 cell lines. To isolate mutant muscle cell lines,
we made use of a transgenic mouse bearing a g-IFN-inducible,
temperature-sensitive T-antigen transgene (Jat et al., 1991) (Immorto-
mouse, Charles River Laboratories, Wilmington, MA). Cells from dif-
ferent tissues of this mouse, including muscle, can be maintained for
several passages in an undifferentiated state under permissive conditions
(33°C, with g-IFN) in vitro (Morgan et al., 1994). Mice heterozygous for
both rapsyn and the immortalizing transgene (double heterozygotes)
were generated in crosses between mice bearing the transgene and
rapsyn 1/2 mice. Double heterozygotes were then crossed with rapsyn
1/2 mice to generate rapsyn mutants and controls bearing the transgene.
Litters from such crosses were dissected at embryonic day 18 (E18), and
muscles from the forelimbs and hindlimbs of each pup were trypsinized.
The resulting suspension of cells was diluted and plated on 3 cm plates
and maintained at 33°C in F10 medium containing 20% fetal bovine
serum, 3% chick embryo extract, and 4 U/ml g-IFN. Pups from each
litter were genotyped by PCR of tail DNA within 2 d of initial plating;
cell cultures from mutants and controls that tested positive for the
transgene were then trypsinized, counted, and replated at clonal density.
Colonies were allowed to develop over the next 10 d, and each colony was
expanded. We picked three clonal cell lines for further studies: 11-4 and
11-7 are rapsyn 2/2 lines and 12-10 is a wild-type (rapsyn 1/1) cell line.
Analysis of 11-4 versus 11-7 cells revealed no clonal variability in the
association of AChRs with postsynaptic proteins (data not shown). We
used 11-7 for most experiments, however, because they routinely formed
myotubes more efficiently than 11-4.
Antibodies. Affinity-purified rabbit polyclonal antibodies against
rapsyn, designated 5943 (W. D. Phillips et al., 1991), were a generous gift
from the late Dr. J. P. Merlie and from Dr. J. R. Sanes (Washington
University, St. Louis, MO). In immunoblot experiments with cultured
muscle cells, the antibody recognized a major protein of ;43 kDa that
was specifically absent from rapsyn 2/2 myotubes and thus represents
rapsyn (see Fig. 3). A rabbit polyclonal antiserum, aDRP, reactive with
utrophin (Ohlendieck et al., 1991), was a gift from Dr. K. P. Campbell
(University of Iowa, Iowa City, IA). In immunoblots made with extracts
from cultured myotubes, this antibody labeled a single protein band of
;400 kDa, whose mobility was very similar to utrophin found in purified
sarcolemma of mouse skeletal muscle (Ohlendieck et al., 1991). The
rabbit antiserum recognizing b-dystroglycan was made against a peptide
corresponding to the C-terminal 20 amino acid of mouse b-dystroglycan
and was produced commercially by Research Genetics (Huntsville, AL).
Immunoblotting with preimmune serum and immunoprecipitations with
an excess of free b-dystroglycan immunizing peptide established the
specificity of the antibody (J. E. Sugiyama and Z. W. Hall, unpublished
observations). In all cases, b-dystroglycan was detected as a band of ;46
kDa, similar to its molecular weight in dystrophin/utrophin glycoprotein
complexes purified from rabbit skeletal muscle (Ibraghimov-
Beskrovnaya et al., 1992). In addition, a mouse monoclonal antibody
against b-dystroglycan, purchased from Novocastra Labs (Burlingame,
CA), reacted with a protein of the same molecular weight in immuno-
blots made from C2 myotubes (data not shown), showing that our
antibody indeed recognizes b-dystroglycan in cultured muscle cells.
mAb124, a rat monoclonal antibody against the AChR b subunit, was a
kind gift from Dr. J. Lindstrom (University of Pennsylvania, Philadel-
phia, PA). The mouse monoclonal antiserum mAb 88B, reactive with the
AChR g and d subunits, and mAb SYN1351 (Froehner et al., 1987), a
mouse monoclonal antibody reactive with all syntrophin isoforms (a1,
b1, and b2) (Peters et al., 1994), were generously provided by Dr. S. C.
Froehner (University of North Carolina, Chapel Hill, NC). In C2 myo-
tube extracts, syntrophin isoforms were detected as three major protein
bands between 55 and 65 kDa (see Fig. 2). A rat monoclonal antiserum
recognizing the mouse transferrin receptor RI7 217 (Lesley et al., 1989)
was a generous gift from Dr. J. Lesley (The Salk Institute, San Diego,
CA). To detect src-related kinases, we used src-CT, a rabbit polyclonal
antibody reactive with at least src, fyn, and yes (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) (Fuhrer and Hall, 1996). The rabbit polyclonal
antiserum recognizing MuSK was as described (Fuhrer et al., 1997). For
phosphotyrosine immunoblotting, a mixture of two commercially avail-
able mouse monoclonal antibodies was used, 4G10 (Upstate Biotechnol-
ogy, Lake Placid, NY) and PY20 (Transduction Labs, Lexington, KY).
Isolation of AChRs and co-precipitation. To examine association of
postsynaptic proteins with the AChR, myotubes were rinsed on ice
with PBS supplemented with 1 mM Na-orthovanadate and 50 mM NaF
and extracted at 4°C in lysis buffer. For these assays, most of the
chemicals were purchased from Sigma. The conditions for lysis were
mild, i.e., 1% digitonin, 50 mM NaCl, 30 mM triethanolamine, pH 7.5,
5 mM EGTA, 5 mM EDTA, 50 mM NaF, 2 mM Na-orthovanadate,
10 mM p-nitrophenylphosphate, 50 mM phenylarsine-oxide, 1 mM ben-
zamidine, 1 mM N-ethylmaleimide, 1 mM Na-tetrathionate, 1 mM PMSF,
25 mg/ml aprotinin, and 25 mg/ml leupeptin. Cells were lysed for 30 min,
and insoluble material, such as nuclei and cytoskeletal elements, was
removed by centrifugation at 18,000 3 g for 5 min. To precipitate the
AChR, the cleared lysates were incubated with a-bungarotoxin (a-BT)
coupled to Sepharose beads (Gu and Hall, 1988). In the case of control
samples, we added an excess (10 mM) of free uncoupled a-bungarotoxin
to lysates to compete with AChR binding to the resin. Other control
samples were precipitated with uncoupled Sepharose beads. Beads were
then washed twice with wash buffer 1 (0.4% digitonin, 470 mM NaCl, 30
mM triethanolamine, pH 7.5, 5 mM EGTA, 5 mM EDTA, 2 mM Na-
orthovanadate, 1 mM PMSF, 10 mM p-nitrophenylphosphate, 50 mM
phenylarsine-oxide, 50 mM NaF) and twice in wash buffer 2 (same as 1
but containing 120 mM NaCl) and boiled in SDS-PAGE sample buffer.
The proteins were separated by reducing SDS-PAGE and transferred to
nitrocellulose membranes. To detect AChR-associated proteins, the ni-
trocellulose was probed with the appropriate antibodies, and immuno-
reactive bands were visualized using horseradish peroxidase-conjugated
secondary antibodies and enhanced chemiluminescence (ECL, Amer-
sham Corporation, Arlington Heights, IL). Some immunoblots were
stripped by incubating them for 20 min in 200 mM glycine, 0.1% Tween
20, pH 2.5; the blots were then reprobed with src-CT to examine
src-related kinases or with mAb 124 or mAb 88B to confirm that equal
amounts of AChRs were present in all lanes. Experiments were repeated
at least four times, and representative samples are shown in Figures 2
and 6. Quantitation of ECL immunoblotting data was performed by
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scanning films containing gray, nonsaturated signals with a computerized
densitometer (LaCie Silverscanner IV) and using the NIH Image 1.54
software. Scanning data were evaluated by one-way ANOVA followed by
pair-wise Bonferroni’s t tests.
To study tyrosine phosphorylation of AChRs, AChR-associated
MuSK, and total MuSK, myotubes were treated with agrin and extracted
in lysis buffer as described above. Cleared lysates were split into two
parts and either incubated with a-bungarotoxin-Sepharose beads to
isolate the AChR and receptor-associated MuSK or with MuSK antibod-
ies followed by protein A-Sepharose to precipitate MuSK. Bead-
precipitated proteins were eluted into SDS sample buffer, subjected to
SDS-PAGE, and analyzed by phosphotyrosine immunoblotting. Because
of the similarities in the precipitation protocols using MuSK antibodies
and toxin-Sepharose, we refer to the latter as “Tox-IP” in Figures 7 and
5, although no antibodies are used in this case. The experiments were
performed three times, and representative samples are shown in Figure
7. Evaluation was performed by densitometric scanning of nonsaturated
signals and statistical analysis as described above.
These experiments revealed the presence of a protein complex in C2
myotubes containing AChRs in association with rapsyn, MuSK, src-
related kinases, b-dystroglycan, and utrophin. To test the relative
strength of these protein interactions, we used a range of progressively
more stringent conditions. These were based on the lysis and wash buffers
detailed above, with the following substitutions: (1) digitonin was re-
placed by Nonidet P-40 (NP-40) or Triton X-100 (Tx-100) in lysis and
wash buffers; (2) digitonin was replaced with a fixed concentration of 1%
Tx-100 in both lysis and wash buffers; (3) digitonin was replaced with
fixed concentrations of 1% Tx-100 and 0.5% deoxycholate in both lysis
and wash buffers; (4) same as (3) but 470 mM NaCl was included in the
lysis buffer, i.e., cell lysis was performed in the presence of high salt; and
(5) in addition, an extremely mild procedure was applied, in which the
lysis buffer contained digitonin as described, but all wash buffers con-
tained only low salt, i.e., 120 mM NaCl. Over this range of conditions, few
changes in protein binding were observed. Substituting digitonin with any
other detergent abolished association of AChRs with b-dystroglycan,
whereas under condition (4), no agrin-dependent increase of the AChR–
MuSK interaction was seen.
Fluorescence microscopy. To visualize the distribution of AChR on
the surface of rapsyn 2/2 and wild-type myotubes, these cells were
grown and fused on gelatin-coated chamber slides (Nunc). Myotubes
were treated with or without 0.1 nM neural agrin for 16 hr and
incubated with 0.5 mg /ml rhodamine-conjugated a-bungarotoxin. Af-
ter washing and fixation in 2% paraformaldehyde, cells were mounted
with p-phenylenediamine and examined under a Nikon Microphot-
FXA fluorescence microscope at a final magnification of 4003.
RESULTS
AChRs are associated with rapsyn in C2 myotubes
We examined the associations of AChRs with other proteins by
extracting the AChR from C2 myotubes in a buffer containing 1%
digitonin, a mild detergent, precipitating it with a-bungarotoxin
(a-BT) conjugated to Sepharose beads, and probing immunoblots
of the precipitated proteins using the relevant antibodies. To test
whether proteins were bound to the resin specifically through
their association with the AChR, free a-BT was added to extracts
before the purification or unconjugated Sepharose was used, as
described previously (Fuhrer et al., 1997).
In our initial experiments, we looked for the presence of the
protein rapsyn, because it has been postulated to be associated
with the AChR as the result of cross-linking experiments (Burden
et al., 1983) and because of its ability to cluster AChRs in
heterologous cells (Froehner et al., 1990; W. P. Phillips et al.,
1991; Gillespie et al., 1996; Apel et al., 1997). Other observations
that implied a complex between rapsyn and the AChR include
their 1:1 stoichiometry in C2 myotubes (LaRochelle and Froeh-
ner, 1987) and structural investigations that revealed a protein,
presumably rapsyn, associated with Torpedo AChR on its cyto-
plasmic surface (Unwin, 1993). Our immunoblotting experiments
with rapsyn-specific antibodies revealed that the precipitated
AChR is indeed associated with an immunopositive band that
migrates as a protein of 43 kDa and represents rapsyn (Fig. 1).
The band was not present when an excess of free toxin was added
to the extract or when unconjugated Sepharose was used, con-
firming the specificity of the interaction. By comparing the
amount of protein precipitated with the amount of rapsyn in the
original extract, we estimate that 1.13 6 0.29% of the total rapsyn
is specifically bound to the toxin beads (mean 6 SD; data from six
experiments). Because only 14.9% of the total AChR in C2
lysates is recovered on a-BT-Sepharose (Fuhrer et al., 1997), we
calculate that at least 7.5% of the total rapsyn in the extract is
associated with the AChR (Table 1). Because rapsyn is likely to
be poorly extracted relative to the AChR (Froehner, 1991), our
results are consistent with the association of a significant propor-
tion of the total rapsyn in muscle cells with the AChR.
To our knowledge, this is the first demonstration of a specific
co-precipitation of soluble rapsyn with the AChR in extracts of
muscle cells. Biochemical co-purification of these two proteins
has proven to be difficult (Froehner, 1991; Bezakova and Bloch,
1998; Colledge and Froehner, 1998b), and a recent report showed
protein co-precipitation but did not test the specificity of the
proposed interaction or mention proteins that are excluded from
the precipitation procedure (Mitsui et al., 1996). Another recent
study described weak binding between recombinant AChR and
rapsyn proteins using protein overlay assays (Buckel et al., 1998).
The difficulties in biochemical co-purification of rapsyn and the
AChR from extracts of muscle or Torpedo most likely originate
from difficulties in extracting rapsyn from the cytoskeleton and its
protease sensitivity. With respect to the latter, we have observed
that within hours after cell extraction, the amounts of rapsyn and
the AChR in the cell lysate decrease substantially (C. Fuhrer
and Z. W. Hall, unpublished observations). For these reasons,
we assume that our observed interaction originates from a
Figure 1. Rapsyn is associated with the AChR. C2 myotubes were
treated with 5 nM neural agrin as indicated and lysed in a buffer contain-
ing 1% digitonin. AChRs were isolated using a-BT coupled to Sepharose
beads; as controls, an excess (10 mM) of free soluble toxin was added (1T )
or unconjugated Sepharose was used ( C). Samples were analyzed by
SDS-PAGE and immunoblotting with a rapsyn-specific antiserum. For the
bottom part, the blot was stripped and reprobed with mAb 88b, which
recognizes the AChR g and d subunits. L indicates a fraction (0.3%) of
the total lysate.
Fuhrer et al. • Protein Interactions with the AChR J. Neurosci., August 1, 1999, 19(15):6405–6416 6407
much more pronounced in vivo association between rapsyn and
the AChR.
Association of the AChR with other synaptic proteins
We used the same method to investigate the association of the
AChR with other postsynaptic proteins. Using specific antibodies,
we looked for the presence of three proteins that are part of the
dystrophin/utrophin glycoprotein complex, b-dystroglycan, utro-
phin, and syntrophin. Small amounts of the first two proteins were
specifically associated with the AChR (Fig. 2A,B). A 400 kDa
band was immunopositive for utrophin, and a protein of 46 kDa
was reactive with b-dystroglycan antibodies. In both cases, some
of the observed binding was nonspecific, because it could not be
competed with excess toxin and it also occurred to unconjugated
Sepharose. There was a consistent and statistically significant
difference between toxin beads and these controls, however, in-
dicating that utrophin, as well as b-dystroglycan, is specifically
associated with the AChR (also see Fig. 6). In both cases, the
amount of bound protein was low; we calculate that ;0.30% of
total b-dystroglycan and 0.48% of total utrophin are bound to the
AChR in the cell extracts (Table 1). No evidence was found for
binding of syntrophin, the third member of the complex tested.
Using a monoclonal antibody, mAb SYN1351, that recognized all
three major syntrophin isoforms, a1, b1, and b2 (Peters et al.,
1994), in C2 myotube extracts, no immunopositive protein was
detected bound to toxin beads (Fig. 2D). The failure to detect
association with syntrophin indicates that the binding of
b-dystroglycan and utrophin is specific and does not reflect non-
selective protein aggregation. As a further control, we also tested
for the presence of an unrelated membrane protein, the trans-
ferrin receptor, which was not associated with AChRs under any
of the conditions tested (Table 1) (Fuhrer et al., 1997).
The effect of agrin on the interaction of the AChR with
rapsyn, MuSK, src-family kinases, and other proteins
We then tested the effect of agrin treatment on the interaction of
the AChR with rapsyn and other proteins. Agrin did not change
the amount of rapsyn bound to the AChR. Although occasional
variations were seen, no consistent effect of agrin on the associ-
ation was observed (Fig. 1). Even after a 16 hr treatment with a
high dose (5 nM) of neural agrin, conditions under which AChR
cluster formation is maximal (Ferns et al., 1996), the association
remained unchanged as compared with untreated cells, suggest-
ing that the interaction of rapsyn with AChRs in muscle cells is
independent of the agrin signaling pathway.
We have reported previously that the AChR in C2 myotubes is
associated with both of the src-family kinases, src and fyn (Fuhrer
and Hall, 1996), and with the receptor tyrosine kinase MuSK, and
that agrin treatment increases the association of MuSK with
AChRs (Fuhrer et al., 1997). When we examined the effect of
agrin on the association of the AChR with src-family kinases,
however, we found results that were similar to those seen for
rapsyn. Using an antiserum, src-CT, that reacts with several
src-family members including src, fyn, and yes, we found no effect
of agrin treatment on the amount of these proteins associated
with the AChR (Fig. 2C). We also found no consistent effect of
agrin on the association of utrophin and b-dystroglycan with the
AChR, although variations in the binding were occasionally ob-
served (Fig. 2A,B; also see Fig. 6C).
Characteristics of the AChR–protein interactions
To investigate the strength of the observed protein interactions
with the AChR, we used a range of progressively more stringent
conditions to extract C2 myotubes, including up to 1% Triton
X-100, 0.5% deoxycholate, and 470 mM NaCl (see Materials and
Methods). Although most associations were unchanged, we did
find two differences in these experiments. First, substituting dig-
itonin with any other detergent inevitably abolished binding of
the AChR to b-dystroglycan without affecting other constitutive
interactions (Table 1). We were thus able to observe a complex of
the AChR in association with utrophin, kinases, and rapsyn, but
without b-dystroglycan. Second, under the harshest conditions
tested, agrin failed to increase the association of the AChR with
MuSK (Table 1). These data indicate that some protein interac-
tions are very fragile and that we most likely disrupt protein
complexes during even the mildest extraction procedures. Our
calculations on the stoichiometries of the protein interactions are
thus minimal estimates of the associations as they occur in intact
cells and are likely to be merely an indication of much more
pronounced interactions in vivo. Furthermore, MuSK appears to
interact with the AChR in two ways. The first association is
independent of agrin and resistant to harsh conditions, whereas
the second is induced by agrin and disrupted by stringent extrac-
Table 1. Protein interactions with the AChR
Protein
Wild-type cellsa Rapsyn 2/2 cells
Mild extraction Stringent extraction Mild extraction
2Agrin 1Agrin Efficiency b (%) 2Agrin 1Agrin 2Agrin 1Agrin
MuSK 1 11 1.94 6 0.13 1 1 1 1
Rapsyn 1 1 7.58 6 1.94 1 1 N/A N/A
src-related kinases 1 1 0.35 6 0.07 1 1 1 1
Utrophinc 1 1 0.48 6 0.17 1 1 2 2
b-dystroglycanc 1 1 0.30 6 0.04 2 2 2 2
Syntrophin 2 2 0 ND ND ND ND
Transferrin receptor 2 2 0 ND ND ND ND
Data were obtained by incubating C2, rapsyn wild-type, or rapsyn 2/2 myotubes with or without 5 nM neural agrin for 16 hr. Cell lysates were prepared in a buffer containing
1% digitonin and 50 mM NaCl (mild conditions) or 1% Triton X-100, 0.5% deoxycholate, and 470 mM NaCl (stringent conditions), as detailed in Materials and Methods.
AChRs were isolated using a-bungarotoxin-Sepharose, and associated proteins were identified by immunoblotting. ND, Not done; N/A, not applicable.
aAs wild-type cells, C2 and rapsyn wild-type myotubes (12-10) were used.
bThe efficiency of the interaction was calculated for untreated C2 myotubes. It represents the percentage of the total protein associated with total AChR, based on the
observation that 14.9% of AChRs in a cell extract can be isolated on a-BT-Sepharose (Fuhrer et al., 1997). Data represent mean 6 SD of at least five experiments.
cFor utrophin and b-dystroglycan, substantial non-specific binding occurs to the Sepharose resin.
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tion buffers. Thus, different mechanisms appear to underlie con-
stitutive as opposed to agrin-induced association of MuSK with
the AChR. Finally, the range of detergent conditions allowed us
to partially dissect the AChR protein complex. Because
b-dystroglycan is selectively lost under harsh conditions, the ob-
served binding of other proteins to the AChR does not require its
presence. Thus, in the assembled AChR complex in myotubes,
b-dystroglycan does not appear to link other proteins, in partic-
ular, utrophin, to the AChR; instead, these proteins interact with
the AChR independently of b-dystroglycan.
Production and characterization of rapsyn 2/2
cell lines
Because rapsyn has been proposed as a primary adaptor and
anchoring protein of the AChR, linking it to other proteins, we
wished to investigate its role in the association of the AChR with
the proteins mentioned before. For this purpose we made use of
rapsyn-deficient muscle cell lines bearing an immortalizing SV40
T-antigen transgene (Jat et al., 1991; Morgan et al., 1994). Rapsyn
mutant mice bearing the transgene were obtained in crosses
between rapsyn heterozygotes positive for the SV40 T-antigen
transgene and rapsyn 1/2 mice (see Materials and Methods).
Cells dissociated from limb muscles of E18 embryos were plated
at clonal density under permissive conditions (33°C, g-interferon)
for the isolation of muscle cell lines. Each colony was expanded
and tested for fusion (37°C, no g-interferon). Two of the resulting
rapsyn 2/2 cell lines (11-4 and 11-7) formed myotubes that
displayed spontaneous contractions and appeared healthy (see
Fig. 4). No significant difference in overall morphology was seen
as compared with the control wild-type muscle cell line (12-10,
rapsyn 1/1) generated from a wild-type littermate. However, for
both mutant and wild-type cell lines, the overall efficiency of
fusion and myotube formation was lower than that seen with C2
myotubes.
The overall amounts of the AChR, and the proteins associated
with it, were compared in extracts of the rapsyn 2/2 and rapsyn
wild-type cell lines (11-7 and 12-10) by immunoblotting (Fig. 3).
The cellular levels of all proteins examined, including the AChR,
utrophin, b-dystroglycan, syntrophin, src-related kinases, and
MuSK, were indistinguishable in the two cell lines. Only rapsyn,
which was undetectable in the mutant cells, was different. These
results show that rapsyn does not affect the overall levels of these
proteins, nor is it required for the formation of healthy myotubes
in vitro.
When myotubes from the two cell lines were examined for the
presence of AChR clusters using rhodamine-conjugated a-BT
and fluorescence microscopy, the wild-type myotubes showed
occasional clusters, but the mutant cells had none (Fig. 4). More-
over, when treated with agrin, the wild-type myotubes formed
many AChR clusters, but the mutant cells failed to form any
aggregates at all. After treatment of myotubes with 0.1 nM neural
agrin for 16 hr, clusters were absent in the mutant cells, whereas
an abundance of clusters was visible on the wild-type myotubes,
similar to observations with C2 myotubes (Fig. 4; data not
shown). The complete absence of AChR aggregates, in both
Figure 2. Protein associations with the AChR in C2
myotubes. Myotubes were incubated with 5 nM neural
(4,8) or muscle (0,0) agrin as indicated. Cells were then
extracted under mild conditions, using 1% digitonin, and
AChRs were precipitated with a-BT-Sepharose. As con-
trols, an excess (10 mM) of free toxin was added (1T ), or
in some experiments unconjugated Sepharose was used
(C). Precipitates were analyzed by immunoblotting using
specific antibodies as indicated. The AChR content in
each lane was visualized by reprobing stripped blots with
an antiserum, mAb 88b, reactive with the AChR g and d
subunits. For comparison, a fraction (0.2%) of the total
cell lysate was analyzed (L). Solid arrowheads indicate the
proteins detected by the antibodies used for immunoblot-
ting; open arrowheads point to the AChR g and d
subunits.
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untreated and agrin-treated mutant cells, was striking and is in
agreement with results from cultured primary myotubes derived
from rapsyn 2/2 mice (Gautam et al., 1995).
AChR–protein interactions in rapsyn 2/2 myotubes
We then used the rapsyn 2/2 myotubes in our standard precip-
itation experiments to determine whether rapsyn is required for
each of the other protein associations with the AChR that we
detected. We first looked to determine whether rapsyn is required
for MuSK association with the AChR, because experiments in
transfected QT-6 fibroblasts had suggested that rapsyn associates
independently with both the AChR and MuSK (Gillespie et al.,
1996; Apel et al., 1997). When rapsyn 2/2 myotubes were exam-
ined, however, MuSK was found to be associated with the AChR
in a specific manner and with a stoichiometry comparable to that
found in C2 myotubes (Fig. 5) (Fuhrer et al., 1997). We calculate
that 1.46 6 0.46% of the total MuSK in extracts is associated with
the AChR (mean 6 SD from six experiments; see also Table 1)
under conditions in which the efficiency of AChR precipitation is
the same in the two cell lines. We conclude that the constitutive
association of MuSK with the AChR does not require rapsyn.
We found similar results when we examined the association of
the src-related kinases with the AChR in rapsyn 2/2 myotubes
(Fig. 5). The proportion of src-family kinases in the total extract
that was associated with the AChR (0.30 6 0.13% in six experi-
ments) was not significantly different from that found in C2
myotubes (Fuhrer and Hall, 1996). Thus, in muscle cells, rapsyn
is also dispensable for binding of src-related kinases to the
AChR, although in transfected fibroblasts rapsyn is associated
with cell-endogenous kinase activity (Qu et al., 1996).
Different results were found when the isolated AChR from
rapsyn 2/2 myotubes was examined for the presence of proteins
associated with the dystrophin/utrophin glycoprotein complex
Figure 3. Analysis of postsynaptic proteins in rapsyn 2/2 and wild-type
myotubes. Cells (11-7 and 12-10) were lysed in a buffer containing 1%
NP-40, and protein-matches fractions, ;1% of the extracts, were sub-
jected to immunoblotting using utrophin-, MuSK-, or b-dystroglycan-
specific antibodies. Blots were stripped and reprobed with the src-CT
antibody; in a second round of stripping and reprobing, mAb 124 anti-
bodies recognizing the AChR b subunit were used. Parallel lysates were
analyzed by immunoblotting with rapsyn- or syntrophin-specific antisera.
Arrowheads indicate the proteins recognized by the respective antibodies.
Figure 4. Distribution of AChRs on the surface of agrin-treated rapsyn
2/2 and wild-type myotubes. 11-7 and 12-10 cells were grown and fused
on chamber slides and incubated with or without 0.1 nM neural agrin for
16 hr. Surface AChRs were visualized by incubating cells with 0.5 mg/ml
rhodamine-conjugated a-BT, fixing in 2% paraformaldehyde, and exam-
ination by fluorescence microscopy. In rapsyn 2/2 myotubes, both spon-
taneous and agrin-induced AChR clusters are completely absent, whereas
wild-type cells show increased cluster formation in response to agrin.
Scale bar, 20 mm.
Figure 5. Association of the AChR with MuSK and src-related kinases in
rapsyn 2/2 myotubes. Myotubes lacking rapsyn were lysed in a buffer
containing 1% digitonin, and AChRs were precipitated with a-BT cou-
pled to Sepharose beads (TS). As controls, an excess (10 mM) of free toxin
was added (1T ), or unconjugated Sepharose was used (CS). AChR-
associated proteins were detected by immunoblotting using MuSK or
src-CT antibodies, and the presence of the AChR was confirmed by
stripping the src-CT blot and reprobing it with mAb 124 reactive with the
AChR b subunit. L represents 0.2% of the total lysate.
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(Fig. 6). In contrast to results obtained with C2 or rapsyn wild-
type myotubes, no evidence was found for specific binding of
utrophin or b-dystroglycan to the AChR in the mutant cells (Fig.
6A,C). Even under the mildest conditions of extraction, 1%
digitonin and a total salt concentration of 150 mM in lysis and
wash buffers, we could not detect specific associations. Analysis of
several experiments showed that the association of the AChR
with utrophin and b-dystroglycan is statistically significant in the
wild-type cells, although some background binding of these pro-
teins occurs to the Sepharose resin (Fig. 6C). In rapsyn-deficient
myotubes, in contrast, no significant difference was found be-
tween a-BT-Sepharose and control samples including excess free
toxin and uncoupled Sepharose, ruling out a specific association
of the AChR with utrophin and b-dystroglycan in these cells.
Thus, rapsyn is required for the association of the AChR with two
proteins of the dystrophin/utrophin glycoprotein complex, utro-
phin and b-dystroglycan.
Finally, we examined the effects of agrin treatment on the
associations of the various proteins with the AChR in rapsyn 2/2
myotubes. No effect was seen in any case. In particular, agrin did
not increase the association of MuSK with the AChR. In contrast,
in C2 and rapsyn wild-type myotubes, agrin increased the asso-
ciation by ;2.5-fold, as shown in Figure 6B and as reported
previously (Fuhrer et al., 1997). These results suggest that MuSK
associates with the AChR in two ways, in a rapsyn-independent
and a rapsyn-dependent mode, and that the latter occurs as a
response to agrin. These two modes of interaction are consistent
with the observations from C2 myotubes using mild and stringent
extraction buffers, as described above.
These data indicate that in muscle cells, rapsyn mediates inter-
actions of the AChR with two components of the dystrophin/
utrophin glycoprotein complex, utrophin and b-dystroglycan, but
not with src-related kinases. In the case of MuSK, it is not
involved in the constitutive interaction but is necessary for the
increased association observed after treatment with agrin. Be-
cause rapsyn 2/2 myotubes do not form any AChR clusters,
either spontaneously or in response to agrin, the rapsyn-
independent binding of src-related kinases and MuSK in these
cells must occur to diffusely distributed AChRs.
In summary, in myotubes, the AChR is specifically associated
with multiple other proteins, including rapsyn, utrophin,
b-dystroglycan, src-related kinases, and MuSK. The rapsyn de-
pendence of some of these interactions indicates a role of rapsyn
in selected associations and rules out general protein aggregation
as a cause for the observed AChR protein complex. Several
additional observations point toward the specificity of the protein
interactions in the complex. First, neither syntrophin, another
postsynaptic component of the dystrophin/utrophin glycoprotein
complex, nor the transferrin receptor, a membrane protein, is
associated with the AChR, although both are easily detected in
muscle extracts. Second, the observed interactions occur with
Figure 6. Effect of agrin on association of proteins with the AChR in
rapsyn 2/2 myotubes. A, Myotubes lacking rapsyn (11-7) and control
wild-type cells (12-10) were treated for 16 hr with 5 nM of neural (4,8) or
muscle (0,0) agrin as indicated. Cells were extracted under mild condi-
tions, using 1% digitonin, and AChR-associated proteins were detected by
a-BT-Sepharose precipitation and immunoblotting using the indicated
antibodies. As a standard, 0.2% of the total lysate was analyzed (L).
Arrowheads point to the proteins recognized by the respective antibodies.
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B, Quantitation of the AChR–MuSK interaction. MuSK immunoblots
made from samples treated as described in A were quantitated by densi-
tometric scanning of films, and values of untreated cells were set to 100%.
Data represent mean 6 SD of at least five experiments. C, Quantitation
of the AChR–utrophin and AChR–b-dystroglycan interaction. Immuno-
blots as shown in A were quantitated by densitometric scanning, and
values of agrin-treated control samples containing excess toxin (1T ) were
set to 100%; other values were calculated accordingly. Data represent
mean 6 SD of at least six experiments. *Differs significantly from control
( p , 0.05, by ANOVA followed by Bonferroni’s t test).
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different stoichiometries, ruling out general protein aggregation
(Table 1). Finally, the proteins are dissociated from the AChR at
different ionic strengths, with most of them stable in stringent
conditions as described above.
Tyrosine phosphorylation of MuSK and the AChR in
rapsyn 2/2 myotubes
Neural agrin causes tyrosine phosphorylation of two of the pro-
teins that we observe in the AChR complex, MuSK and the
AChR itself (Wallace et al., 1991; Glass et al., 1996). MuSK
phosphorylation, of both the total pool and the AChR-associated
fraction, occurs within minutes after agrin treatment and is par-
alleled by phosphorylation of the AChR b subunit (Glass et al.,
1996; Fuhrer et al., 1997). We examined the dependence of each
of these phosphorylation events on rapsyn by determining their
occurrence in rapsyn 2/2 myotubes. To examine the phosphor-
ylation of total MuSK, the myotubes were treated with neural or
muscle agrin; MuSK was immunoprecipitated and examined by
phosphotyrosine immunoblotting. The results obtained with
rapsyn 2/2 myotubes were similar to those seen in C2 and rapsyn
wild-type myotubes because MuSK was phosphorylated within 15
min of treatment with neural but not muscle agrin (Fig. 7A), as
shown previously by Apel et al. (1997). In addition, neural but not
muscle agrin induced tyrosine phosphorylation of the pool of
MuSK that is associated with the AChR (Fig. 7A). A statistical
evaluation of several experiments showed no difference in the
agrin-induced tyrosine phosphorylation of AChR-bound MuSK
between wild-type and rapsyn-deficient myotubes (Fig. 7C). The
lower relative intensity of the phosphorylated bands representing
AChR-bound MuSK in rapsyn 2/2 and wild-type myotubes
relative to C2 myotubes (Fuhrer et al., 1997) is presumably
attributable to the lower proportion of myotubes as compared
with myoblasts in the cultures, which explains the higher back-
ground in these cells. However, because agrin-induced phosphor-
ylation of total and AChR-bound MuSK occurs indistinguishably
and rapidly in both rapsyn 2/2 and wild-type myotubes, we
conclude from these experiments that rapsyn is not required for
the tyrosine phosphorylation of either the total pool of MuSK or
MuSK that is associated with the AChR.
In contrast, when phosphorylation of the AChR was examined,
we saw a striking and significant difference between rapsyn 2/2
and wild-type myotubes. Unlike in wild-type cells, the AChR b
subunit was not phosphorylated efficiently in agrin-treated rapsyn
2/2 myotubes (Fig. 7A,C), as shown previously by Apel et al.
(1997), although there was no difference in the amounts of a-BT-
precipitated AChRs and MuSK between the two cell lines (Fig.
7B). In addition, we found that the weak constitutive tyrosine
phosphorylation of the AChR b subunit, which is observed inde-
pendently of neural agrin in wild-type cells, is also reduced in
rapsyn 2/2 myotubes (Fig. 7A,C). These experiments show that
rapsyn is essential for constitutive AChR phosphorylation, as well
as the agrin-induced AChR phosphorylation, one of the early
events in agrin signaling, but not for activation of total and
AChR-bound MuSK.
DISCUSSION
In this study, we show that the AChR is associated with rapsyn
and, to a lesser degree, utrophin and b-dystroglycan. Because it
also interacts with src, fyn, and MuSK (Fuhrer and Hall, 1996;
Fuhrer et al., 1997), the AChR has multiple specific associations
with other proteins in myotubes. The rapsyn dependence of the
utrophin and b-dystroglycan associations, together with the inter-
action between these two proteins (James et al., 1996), suggests a
complex containing at least four proteins—AChR, rapsyn, utro-
phin, and b-dystroglycan. Although we do not know whether this
same complex also contains src-family kinases and MuSK, the
occurrence of these associations in aneural myotubes shows that
the AChRs are part of one or more complexes that are preformed
before synaptogenesis; these complexes may thus play a role in
the initiation and growth of the postsynaptic specialization.
Molecular organization of the proteins associated with
the AChR
Of the proteins associated with the AChR, rapsyn is the most
abundant. Rapsyn is known to be in close contact with the AChR
and is present in a 1:1 stoichiometry with the AChR (Burden et
al., 1983; LaRochelle and Froehner, 1987). Despite these and
other long-standing indications that the two proteins are com-
plexed, to our knowledge rapsyn has never been previously co-
purified or co-precipitated specifically with the AChR, probably
because of the difficulty of extracting rapsyn from the insoluble
cytoskeleton and its sensitivity to proteases (Froehner, 1991). For
these and other reasons, our calculation on the stoichiometry of
the AChR–rapsyn interaction is likely to be merely an indication
of a more pronounced interaction occurring in vivo. One possi-
bility, consistent with the 1:1 stoichiometry, is that all surface
AChR molecules, both clustered and unclustered, are complexed
to rapsyn in C2 myotubes. In support of this notion, both rapsyn
and the AChR are diffusely distributed in mutant myotubes
lacking AChR clusters (Gordon et al., 1993). Their association
may occur initially intracellularly before surface transport, be-
cause both rapsyn and AChRs are associated with subpopulations
of post-Golgi vesicles in Torpedo electrocytes (Bignami et al.,
1998).
AChRs also interact in a rapsyn-dependent manner with
b-dystroglycan and utrophin, two components of the dystro-
phin /utrophin glycoprotein complex. On the basis of the inter-
action between these two proteins (James et al., 1996), the
b-dystroglycan could be bound to the AChR complex through
utrophin. Utrophin, however, does not appear to be bound
through b-dystroglycan, because under high salt conditions,
b-dystroglycan is selectively lost from the complex. Our experi-
ments are thus consistent with a novel model in which the AChR
interacts directly with rapsyn, which is bound, either directly or
through an intermediary protein, to utrophin, which is bound to
b-dystroglycan (Fig. 8). We cannot exclude the possibility that
b-dystroglycan is necessary for recruitment of other proteins
(such as utrophin) during formation of this AChR protein com-
plex. Once these proteins are bound, however, b-dystroglycan is
no longer required for their continued association with the
complex.
These findings define a role for rapsyn as the link between the
AChR and the dystrophin/utrophin glycoprotein complex. At
endplates, utrophin colocalizes precisely with AChRs at the
crests of the postsynaptic folds (Colledge and Froehner, 1998a);
our observed association of utrophin with the AChR complex
may underlie this correct localization. By providing a cytoskeletal
link early in development, utrophin may thus hold the AChR
complex in its proper subcellular localization during postsynaptic
differentiation. Indeed, in utrophin-deficient mice, the density of
AChRs and the number of postsynaptic folds are reduced (De-
coninck et al., 1997; Grady et al., 1997). Because these effects are
subtle, however, other molecules and links are also important for
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postsynaptic differentiation and might compensate in the absence
of utrophin.
In addition to linking the AChR to utrophin, rapsyn may
also form a link to b-dystroglycan, based on its ability to cluster
this protein in transfected fibroblasts and to interact with
b-dystroglycan in biochemical assays (Apel et al., 1995; Cartaud
et al., 1998). Thus, at the adult endplate, multiple rapsyn-
dependent links between the AChR and the utrophin glycopro-
tein complex may exist to ensure maximal stabilization of
AChRs.
We have shown previously that src and fyn are bound to the
AChR (Fuhrer and Hall, 1996). As aggregated rapsyn is associ-
ated with an endogenous tyrosine kinase in transfected QT-6
fibroblasts (Qu et al., 1996), Apel et al. (1997) have suggested that
src-related kinases bind to the AChR via rapsyn, but our exper-
iments demonstrate that in myotubes these kinases interact with
AChRs independently of rapsyn. Together, these results suggest
that interactions between rapsyn and src-related kinases may also
occur independently of the AChR. A similar situation occurs in
the case of MuSK; we show that MuSK is associated indepen-
dently of rapsyn with AChRs in untreated rapsyn 2/2 myotubes,
whereas MuSK colocalizes with rapsyn in co-transfected fibro-
blasts (Gillespie et al., 1996; Apel et al., 1997). Thus, both MuSK
and src-family kinases may have an AChR-independent interac-
tion with rapsyn as well as a rapsyn-independent interaction with
the AChR.
In summary, our work on the rapsyn 2/2 myotubes shows that
the AChR has two types of interactions with postsynaptic pro-
teins: those that depend on rapsyn and those that do not. These
findings modify and extend previously proposed rapsyn-mediated
protein interactions that were largely based on protein colocal-
ization in transfected QT-6 fibroblasts.
Agrin signaling and AChR–protein interactions
As postsynaptic AChR clusters are induced by agrin during
synaptogenesis, we were particularly interested in examining
agrin’s effects on protein associations with the AChR. To our
surprise, agrin had no effect on most associations, except an
increase in the case of MuSK (Fuhrer et al., 1997). This increase
appears to be a biochemical correlate of the co-extensive cluster-
ing of both proteins, consistent with its absence in rapsyn 2/2
myotubes. Furthermore, our results reveal two types of interac-
tions of MuSK with the AChR: a rapsyn-independent interaction
that occurs in the absence of agrin and a rapsyn-dependent
interaction that is induced by agrin. The latter has an interesting
parallel in transfected QT-6 cells, where coclustering of MuSK
with AChRs depends on rapsyn (Gillespie et al., 1996; Apel et al.,
1997). Provided that this represents biochemical interactions,
QT-6 cells thus appear as a “short-cut” model for agrin- and
rapsyn-mediated protein clustering. They allow protein aggrega-
Figure 7. Agrin causes efficient tyrosine phosphorylation of AChR-
bound MuSK, but not of the AChR b subunit, in rapsyn 2/2 myotubes.
Rapsyn 2/2 (11-7) and wild-type myotubes (12-10) were treated with 1
nM neural (4,8) or muscle agrin (0,0) as indicated. A, Lysates were split
into two parts and incubated either with a-BT-Sepharose beads (Tox-IP)
to isolate AChRs or with MuSK antibodies and protein A-Sepharose
beads to precipitate MuSK (MuSK-IP). Samples were analyzed by phos-
photyrosine immunoblotting, and proteins were identified by their mo-
lecular weight and by stripping and reprobing the blots with the appro-
priate antisera (data not shown). Agrin causes phosphorylation of total
and AChR-bound MuSK in both cell types. Phosphorylation of the AChR
b subunit is much stronger in the wild-type cells; a shorter exposure of the
blots in the middle section reveals a strong agrin-induced signal in the
wild-type cells and no signal at all in the mutant (data not shown). B,
Levels of AChR-associated MuSK and AChRs isolated on toxin beads are
equal in rapsyn 2/2 and wild-type cells. AChRs were precipitated from
lysates of mutant and wild-type cells, and samples were analyzed by
immunoblotting with MuSK or AChR g/d-specific antibodies. L, 0.3% of
4
the total lysate was analyzed as a standard. C, Quantitation of tyrosine
phosphorylation of AChR-bound MuSK and the AChR b subunit. Im-
munoblots made from samples treated for 40 min as described in A were
quantitated by densitometric scanning of films. Short exposures of films
were used that contained nonsaturated signals. The intensities were nor-
malized for the amount of AChR-bound MuSK, as revealed in a toxin
precipitation followed by a MuSK blot ( B). Values of untreated wild-type
cells were set to 100%, and other values were calculated accordingly. Data
represent mean 6 SD of three experiments. *Differ significantly from
control ( p , 0.05, by ANOVA followed by Bonferroni’s t test), but not
from each other.
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tions to occur that in myotubes are regulated in a more complex
way by agrin, emphasizing the need to analyze AChR–protein
interactions in myotubes.
Agrin causes tyrosine phosphorylation of the AChR b subunit,
which may result from a cascade in which agrin activates MuSK,
leading to activation of AChR-bound src-related kinases, which
phosphorylate the AChR (Fuhrer et al., 1997). In rapsyn 2/2
myotubes, as in staurosporine-treated C2 myotubes (Fuhrer et al.,
1997), agrin activates total and AChR-bound MuSK, but the
AChR is not phosphorylated efficiently, suggesting that rapsyn is
required for a step downstream of MuSK. Because src-related
kinases bind to AChRs independently of rapsyn, presumably
their activation or the activation of an unknown intermediary
protein must require rapsyn. Rapsyn could thus hold AChR-
bound MuSK and src-related kinases in a conformation that
allows activation of one kinase by the other, or it may itself
interact with a kinase or other protein that mediates activation. In
both scenarios, rapsyn appears as a scaffolding molecule involved
in signal transduction. These roles may be mediated by the vari-
ous protein domains of rapsyn (for review, see Colledge and
Froehner, 1998b) and are reminiscent of ion channel-binding
proteins at central synapses, e.g., PSD-95 at glutamatergic syn-
apses (Kennedy, 1997; O’Brien et al., 1998).
Most of our observed AChR–protein interactions are un-
changed by agrin, implying that they can occur with diffusely
distributed AChRs. We show this explicitly for src-related kinases
and a fraction of MuSK, which interact with AChRs in rapsyn-
negative myotubes lacking spontaneous AChR clusters. For
rapsyn, in particular, its interaction with unclustered AChRs is a
novel idea and contrasts with earlier models that postulated that
rapsyn forms a scaffold for the recruitment of AChRs and other
proteins (W. P. Phillips et al., 1991). Our observations rather
suggest that conformational changes and/or additional proteins
are involved in docking diffusely distributed pre-existing AChR–
rapsyn complexes at sites of nascent AChR clusters. Such sites
may initially be marked by MuSK, perhaps in association with
some of the AChRs, consistent with the localization of MuSK at
mutant endplates in rapsyn 2/2 mice (Fig. 8) (Apel et al., 1997).
These observations raise the new concept that the AChR, while
still diffusely distributed, serves as a scaffold to which kinases as
well as anchoring proteins are attached. Indeed, these preas-
sembled complexes of AChRs and other proteins may form the
functional building blocks for agrin-induced AChR clusters. Sev-
eral observations support this notion indirectly. For example,
expression of a chimeric membrane-bound, activated MuSK ki-
nase domain throughout myotubes causes phosphorylation but
Figure 8. Model showing protein interactions with the
AChR and steps in agrin-induced clustering of postsynaptic
proteins. A, In the absence of nerves and neural agrin,
diffusely distributed protein complexes exist in which
rapsyn, b-dystroglycan, utrophin, MuSK, and src-related
kinases interact with AChRs. Rapsyn mediates interaction
of the AChR with utrophin and b-dystroglycan but not with
MuSK and src-related kinases. We assume that all AChRs
are complexed with rapsyn and that sites of nascent AChR
clusters are marked by MuSK, perhaps in association with
some AChR. B, Neural agrin leads to a link of the pre-
existing protein aggregates, using MuSK and rapsyn as ef-
fectors, thereby increasing the interaction between MuSK
and AChRs in a rapsyn-dependent way. For more details,
see Results. p, Phosphotyrosine; src, src-related kinases;
b-DG, b-dystroglycan; a-DG, a-dystroglycan.
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not clustering of AChRs, consistent with the assumption that
MuSK’s ectodomain and its association with AChRs are crucial
for cluster formation (Glass et al., 1997). Furthermore, in AChR
e subunit-deficient recombinant mice, many postsynaptic compo-
nents are gradually lost along with AChRs during the short life
span of these mice, demonstrating a crucial stabilizing effect of
AChRs on other proteins at endplates (Witzemann et al., 1996;
Missias et al., 1997).
Our data thus imply that neural agrin acts to attach preas-
sembled, diffusely distributed AChR complexes to the sites of
nascent clusters (marked by MuSK) underlying nerve terminals
(Fig. 8). This attachment appears to occur by direct or indirect
binding of the rapsyn in the AChR–protein complexes to MuSK,
leading to the observed increase in the AChR–MuSK interaction.
The clustered complex containing proteins required for synapto-
genesis (agrin, MuSK, rapsyn, and AChRs) then acts as the
scaffold that supports the growth and stabilization of the cluster
and the further elaboration of the postsynaptic membrane. A
crucial aim of future experiments will be to describe more fully
the molecular interactions and the proteins that underlie these
events.
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